Skip to main content
Equibles
NTRR logo

NTRR · Neutra Corp.

Track NTRR — free

Use NTRR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NTRR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 +0.00 (+0.00%) At close · Nov 12
Rebalance outlook locked
Going-concern doubt — flagged Aug 7, 2024

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise a substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 7, 2024
Market Cap
$291,790
Shares
2.92B
Volume · Nov 12 5000 Avg daily vol (3M) 7.67M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.00 Open$0.00 Day$0.00–0.00 52W close$0.00–0.00 Avg vol 30d9.8M Short int13 · 0.0% of shares · 1.0d Short vol73% DataJan 2020–Nov 2026 Filing10-Q · Aug 7

Latest documents

2024
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$17,397
Trailing 12 months
Net income (TTM)
−$473,832
Trailing 12 months
Revenue growth YoY
-94.4%
Year over year
Operating margin
-1,457.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+104.3%
Year over year · more shares
Price change (1Y)
-50.0%
Trailing year
Short interest
—
Latest settlement
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Neutral Sentiment Bearish Fundamentals Weak Quant / Vol High
Market backdrop VIX 18.7 · elevated Equity put/call 0.72
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg 0%
above
Price vs 50-day avg 0%
above
RSI (14) 45
neutral
MACD trend Negative
52-week position 0%
near low
Momentum
relative strength
Neutral
1-month return 0%
trailing
6-month return 0%
trailing
YTD return 0%
this year
Relative strength −2%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of shares out · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Weak
Revenue growth −26%
Y/Y
Gross margin 52%
expanding
Free cash flow $-193.5K
Balance sheet $522.9K
net debt
Quant / Vol
risk profile
High
Volatility 705%
annualized · 1-yr
Max drawdown −67%
past year
ATR 0.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
0% Neutral
Price vs 50-day avg
0% Neutral
RSI (14)
45 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of shares out · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 0% Range high $0
vs 200-day avg +0% vs 50-day avg +0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NTRR
Neutra Corp.
this stock
$291,790 +0.0% -26.1% — 0.0%
TAK
Takeda Pharmaceutical Co Ltd
 $67.48B +35.5% — — 0.1%
GALDY
Galderma Group AG
 $54.01B +11.7% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $50.93B +39.9% +4.3% 99.2 2.4%
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
 $40.66B — — — 0.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
13
Days to cover
1.0d
Change
+13 sh
View
Short Volume
Short vol %
73%
As of
Nov 9, 2026
Short Total
View
Fails to Deliver
FTD shares
73.6K
Value
$736
As of
Feb 12, 2021
View
Off-Exchange
Off-exchange %
100.0%
Week of
Oct 5, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$68.0K
Net income (FY)
$-561.4K
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 7, 2024
This year
0
View

Performance

5D 20D 120D MTD YTD
NTRR +0.0% +0.0% +0.0% +0.0% +0.0%
SPY +3.3% -1.9% +1.5% +0.2% +11.0%
vs SPY -3.3% +1.9% -1.5% -0.2% -11.0%
Key facts CIK 1512886 Visit website Investor relations